Magnus Financial Group LLC Bio Cardia, Inc. Transaction History

Magnus Financial Group LLC

  • $971 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$42.6 - $58.65 $639,000 - $879,750
-15,000 Closed
0 $0
Q2 2021

Aug 06, 2021
BUY
$48.9 - $74.85 $733,500 - $1.12 Million
15,000 New
15,000 $60,000

About BioCardia, Inc.

BCDA Quotes by TradingView
  • Ticker BCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,758,200
  • Market Cap $41M
  • Description
  • BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...
More about BCDA
Track This Portfolio

Track Magnus Financial Group LLC Portfolio

Follow Magnus Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email